(19)
(11) EP 4 288 063 A1

(12)

(43) Date of publication:
13.12.2023 Bulletin 2023/50

(21) Application number: 21710563.4

(22) Date of filing: 05.02.2021
(51) International Patent Classification (IPC): 
A61K 31/7076(2006.01)
A61K 8/00(2006.01)
A61P 39/06(2006.01)
 A61K 31/715(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7076; A61K 31/715; A61K 45/06; A61P 39/06; A61Q 19/08; A61K 2800/92; A61K 8/73; A61K 8/606; A61K 8/9789
 
C-Sets:
  1. A61K 31/715, A61K 2300/00;
  2. A61K 31/7076, A61K 2300/00;
(86) International application number:
PCT/IB2021/000049
(87) International publication number:
WO 2022/167827 (11.08.2022 Gazette 2022/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Idec Therapeutic
20220 Aregno (FR)

(72) Inventor:
  • FREY, Michel
    20220 Aregno (FR)

(74) Representative: Tranvouez, Edern Morgan 
Brandon IP 64 rue Tiquetonne
75002 Paris
75002 Paris (FR)

   


(54) COMPOSITION FOR CONTROLLING AND/OR PREVENTING OXIDATIVE STRESS COMPRISING AT LEAST S-ADENOSYL METHIONINE AND ASTRAGALUS SP. POLYSACCHARIDES